Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats

a quantitative study

Jun ichi Kawagoe, Koji Abe, Junya Ikuta, Naomi Igarashi, Sadahiro Shimizu, Yoichi Yamauchi, Kyuya Kogure

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The effect of dilazep dihydrochloride (dilazep) against ischemia and reperfusion-induced disruption of blood-brain barrier (BBB) was quantitatively investigated in Slc:Wistar strain rats using Evans blue dye as a BBB destruction indicator. The forebrain of sham-operated animal had a small amount of the dye. A treatment of 3.5-h ischemia plus 2-h reflow extravasated the dye into the brain and markedly increased the dye content as compared with that of sham group (P <0.01 vs. sham group). Continuous infusion (i.v.) of dilazep during cerebral ischemia dose-dependently reduced the increase of the dye content, and a significant reduction was found at 3 mg/kg/h (P <0.05 vs. control group). Evans blue dye extravasation after ischemia was also greatly reduced in saline-perfused brains by the treatment with dilazep. Dilazep has been reported to inhibit edema formation in cerebral ischemia model of spontaneously hypertensive rats. These results suggest that dilazep prevents the ischemic damage of BBB, which may contribute to reduction of the brain edema.

Original languageEnglish
Pages (from-to)485-488
Number of pages4
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume345
Issue number4
DOIs
Publication statusPublished - Apr 1992
Externally publishedYes

Fingerprint

Dilazep
Blood-Brain Barrier
Reperfusion
Coloring Agents
Ischemia
Evans Blue
Brain Ischemia
Brain Edema
Brain
Inbred SHR Rats
Prosencephalon
Wistar Rats
Edema
Control Groups

Keywords

  • Blood-brain barrier
  • Cerebral ischemia
  • Dilazep dihydrochloride
  • Evans blue dye
  • Rat

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats : a quantitative study. / Kawagoe, Jun ichi; Abe, Koji; Ikuta, Junya; Igarashi, Naomi; Shimizu, Sadahiro; Yamauchi, Yoichi; Kogure, Kyuya.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 345, No. 4, 04.1992, p. 485-488.

Research output: Contribution to journalArticle

Kawagoe, Jun ichi ; Abe, Koji ; Ikuta, Junya ; Igarashi, Naomi ; Shimizu, Sadahiro ; Yamauchi, Yoichi ; Kogure, Kyuya. / Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats : a quantitative study. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 1992 ; Vol. 345, No. 4. pp. 485-488.
@article{9aa2ee081a1a41259461333dcdf37071,
title = "Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats: a quantitative study",
abstract = "The effect of dilazep dihydrochloride (dilazep) against ischemia and reperfusion-induced disruption of blood-brain barrier (BBB) was quantitatively investigated in Slc:Wistar strain rats using Evans blue dye as a BBB destruction indicator. The forebrain of sham-operated animal had a small amount of the dye. A treatment of 3.5-h ischemia plus 2-h reflow extravasated the dye into the brain and markedly increased the dye content as compared with that of sham group (P <0.01 vs. sham group). Continuous infusion (i.v.) of dilazep during cerebral ischemia dose-dependently reduced the increase of the dye content, and a significant reduction was found at 3 mg/kg/h (P <0.05 vs. control group). Evans blue dye extravasation after ischemia was also greatly reduced in saline-perfused brains by the treatment with dilazep. Dilazep has been reported to inhibit edema formation in cerebral ischemia model of spontaneously hypertensive rats. These results suggest that dilazep prevents the ischemic damage of BBB, which may contribute to reduction of the brain edema.",
keywords = "Blood-brain barrier, Cerebral ischemia, Dilazep dihydrochloride, Evans blue dye, Rat",
author = "Kawagoe, {Jun ichi} and Koji Abe and Junya Ikuta and Naomi Igarashi and Sadahiro Shimizu and Yoichi Yamauchi and Kyuya Kogure",
year = "1992",
month = "4",
doi = "10.1007/BF00176629",
language = "English",
volume = "345",
pages = "485--488",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats

T2 - a quantitative study

AU - Kawagoe, Jun ichi

AU - Abe, Koji

AU - Ikuta, Junya

AU - Igarashi, Naomi

AU - Shimizu, Sadahiro

AU - Yamauchi, Yoichi

AU - Kogure, Kyuya

PY - 1992/4

Y1 - 1992/4

N2 - The effect of dilazep dihydrochloride (dilazep) against ischemia and reperfusion-induced disruption of blood-brain barrier (BBB) was quantitatively investigated in Slc:Wistar strain rats using Evans blue dye as a BBB destruction indicator. The forebrain of sham-operated animal had a small amount of the dye. A treatment of 3.5-h ischemia plus 2-h reflow extravasated the dye into the brain and markedly increased the dye content as compared with that of sham group (P <0.01 vs. sham group). Continuous infusion (i.v.) of dilazep during cerebral ischemia dose-dependently reduced the increase of the dye content, and a significant reduction was found at 3 mg/kg/h (P <0.05 vs. control group). Evans blue dye extravasation after ischemia was also greatly reduced in saline-perfused brains by the treatment with dilazep. Dilazep has been reported to inhibit edema formation in cerebral ischemia model of spontaneously hypertensive rats. These results suggest that dilazep prevents the ischemic damage of BBB, which may contribute to reduction of the brain edema.

AB - The effect of dilazep dihydrochloride (dilazep) against ischemia and reperfusion-induced disruption of blood-brain barrier (BBB) was quantitatively investigated in Slc:Wistar strain rats using Evans blue dye as a BBB destruction indicator. The forebrain of sham-operated animal had a small amount of the dye. A treatment of 3.5-h ischemia plus 2-h reflow extravasated the dye into the brain and markedly increased the dye content as compared with that of sham group (P <0.01 vs. sham group). Continuous infusion (i.v.) of dilazep during cerebral ischemia dose-dependently reduced the increase of the dye content, and a significant reduction was found at 3 mg/kg/h (P <0.05 vs. control group). Evans blue dye extravasation after ischemia was also greatly reduced in saline-perfused brains by the treatment with dilazep. Dilazep has been reported to inhibit edema formation in cerebral ischemia model of spontaneously hypertensive rats. These results suggest that dilazep prevents the ischemic damage of BBB, which may contribute to reduction of the brain edema.

KW - Blood-brain barrier

KW - Cerebral ischemia

KW - Dilazep dihydrochloride

KW - Evans blue dye

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0026612272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026612272&partnerID=8YFLogxK

U2 - 10.1007/BF00176629

DO - 10.1007/BF00176629

M3 - Article

VL - 345

SP - 485

EP - 488

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 4

ER -